Survival prognosis in advanced HER-2 negative gastric cancer treated with immunochemotherapy: A novel model
The nomogram model developed in this study effectively predicts the survival outcomes of advanced HER-2 negative gastric cancer patients receiving immunotherapy combined with chemotherapy, demonstrating good discrimination and consistency, and providing robust support for personalized clinical treatment decisions.
Authors
- Ke Xu (ORCID: https://orcid.org/0000-0002-8130-1109)
- Qianqian Hao (ORCID: https://orcid.org/0000-0003-1327-0328)
- Yuan James Rao (ORCID: https://orcid.org/0000-0002-9938-2197)
- Geng-Chen Li (ORCID: https://orcid.org/0000-0003-0577-477X)
- Zhengxiang Han (ORCID: https://orcid.org/0000-0003-2463-8933)
- Lijie Ma (ORCID: https://orcid.org/0000-0002-4630-5366)
- Zhiyuan Yao (ORCID: https://orcid.org/0000-0001-6732-7321)
- Gang Bao
- Xiao Ma (ORCID: https://orcid.org/0000-0002-8294-8588)
Institutions
- Xuzhou Medical College (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-11-12
- DOI
- https://doi.org/10.4251/wjgo.v17.i11.112981
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.52